Phase II trial of doxil for patients with metastatic melanoma refractory to frontline therapy.
Year: 1999
Type: article
Study design: Clinical Trial
Source: Oncology Reports
DOI: 10.3892/or.6.5.1097
Institution: The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2058578539
